1. Hung KY, Tsai TJ, Yen CJ, Yen TS. Infection associated
with double-lumen catheterization for temporary haemodialysis: experience of 168 cases. Nephol Dial Transplant 1995;10:247-251.
2. Hoen B, Paul-Dauphin A, Hestin D, Kessler M..
EPIBACDIAL: a multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients. J
Am Soc Nephrol 1998;9:869-876.
3. Cheesbrough JS, Finch RG, Burden RP. A prospective study
of the mechanisms of infection associated with
hemodialysis catheters. J Infect Dis 1986;154:579-589.
4. Maki DG, Weise CE, Sarafn HW. A semiquantitative
culture method for identifying intravenous catheter related
infection. N Eng J Med 1977;296:1305-1309.
5. Cobb DK, High KP, Sawyer RG et al. A controlled trial of
scheduled replacement of central venous and pulmonary-artery catheters. N Eng J Med 1992;327:1062-1068.
6. Pellizer G, De Lalla F. Intravascular catheter infections in
the intensive care unit. In: Ronco C, Bellomo R (eds). Critical Care Nephrology. Netherland, Kluwer Academic
Publisher, 1998:469-477.
7. Canaud B. Haemodialysis catheter-related infection: time for
action. Nephrol Dial Transplant 1999;14:2288-2290.
8. Maki DG, Weise CE, Sarafin HW. A semiquantitative
culture method for identifying intravenous catheter
infection. N Eng J Med 1977;296:1305-1309.
9. Wang EEL, Prober CG, Ford Jones L et al. The
management of central intravenous catheter infections. Pediatr Infect Dis J 1984; 3:110-113.
10. O'Riordan E, Conlon PJ. Hemodialysis catheter bacteremia:
evolving strategies. Current Opinion in Nephrology and
Hypertension 1998;7:639-642.
11. Cleri DJ, Corrado ML, Seligman SJ. Quantitative culture of
intravenous catheters and other intravascular inserts. J
Infect Dis 1980;141:781-786.
12. Dittmer ID, Sharp D, McNulty CA, Williams AJ, banks RA
A prospective study of central venous hemodialysis catheter colonization and peripheral bacteremia. Clin Nephrol 1999;51(suppll):34-39.
13. Schwab S, Besarab A, Beathard G et al. Executive summaries of the NKF-DOQI Clinical practice guideline for vascular access 1997.
14. Trerotola SO, Johnson MS, Shah H, Kraus MA, McKusky
MA, Ambrosius WT, Harris VJ, Snidow JJ. Radiology 1998;207(suppl2):492-496.
15. Sesso R, Barbosa D, Leme, IL, Sader H. Canziani ME, Manfredi S. Draibe S, Pignatari AC. Staphylococcus aureus prophylaxis in hemodialysis patients using central venous catheter: effect of mupirocin ointment. J Am Soc Nephrol 1998;9(suppl 6): 1085-1092.
16. Barbosa D, Pignatari A, Draibe S, Sader H, Leme I,
Manfredi S et al. A randomized trial evaluating topical mupirocin for the prevention of infections related to central venous catheters for hemodialysis. J Am Soc Nephrol 1997;8:152.
17. Schwartz C, Henrickson KJ, Roghmann K, Powell K.
Prevention of bacteremia attributed to luminal colonization of tunneled central venous catheters with vancomysin-susceptible organisms. J Clin Oncol 1990;80:591-597.
18. Boelaert JR, De Smedt R, De Baere YA et al. The
influence of calcium mupirocin nasal ointment on the
82
incidence of Staphylococcus aureus infections in haemodialysis patients. Nephrol Dial Transplant 1989;4:278-281.
19. Man- KA, Sexton DJ, Conlon PJ et al. Catheter related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis. Ann Intern Med 1997;127:275-280.
20. Shaffer D. Catheter-related sepsis complicating long-term, tunneled central venous dialysis catheters: management by guide-wire exchange. Am J Kidney Dis 1995;25:593-596.
21. Beathard GA. Management of bacteremia associated with tunneled-cuffed hemodialysis catheters. J Am Soc Nephrol 1999; 10:5:1045-1049.
83
Thank you for copying data from http://www.arastirmax.com
